Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 269

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Association between completed suicide and bipolar disorder: A systematic review of the literature

Plans, L., Barrot, C., Nieto, E., Rios, J., Schulze, T.G., Papiol, S., Mitjans, M., Vieta, E., Benabarre, A.·2019·Journal of Affective Disorders
DOI 10.1016/j.jad.2018.08.054
Open this paper in CoChat — free account

Abstract

BACKGROUND Completed suicide is a major cause of death in bipolar disorder (BD) patients. OBJECTIVE The aim of this paper is to provide an overall review of the existing literature of completed suicide in BD patients, including clinical and genetic data DATA SOURCES: We performed a systematic review of English and non-English articles published on MEDLINE/PubMed, PsycInfo and Cochrane database (1970-2017). Additional studies were identified by contacting clinical experts, searching bibliographies, major textbooks and website of World Health Organization. Initially we did a broad search for the association of bipolar disorder and suicide and we were narrowing the search in terms included "bipolar disorder" and "completed suicide". STUDY SELECTION Inclusion criteria were articles about completed suicide in patients with BD. Articles exclusively focusing on suicide attempts and suicidal behaviour have been excluded. We used PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) consensus for drafting this systematic review. RESULTS The initial search generated 2806 articles and a total of 61 meeting our inclusion criteria. We reviewed epidemiological data, genetic factors, risk factors and treatment of completed suicide in BD. Suicide rates in BD vary between studies but our analyses show that they are approximately 20-30-fold greater than in general population. The highest risk of successful suicide was observed in BD-II subjects. The heritability of completed suicide is about 40% and some genes related to major neurotransmitter systems have been associated with suicide. Lithium is the only treatment that has shown anti-suicide potential. LIMITATIONS The most important limitation of the present review is the limited existing literature on completed suicide in BD. CONCLUSIONS BD patients are at high risk for suicide. It is possible to identify some factors related to completed suicide, such as early onset, family history of suicide among first-degree relatives, previous attempted suicides, comorbidities and treatment. However it is necessary to promote research on this serious health problem.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2018.08.054

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 189

  1. Akiskal, 2005, Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?, Psychopathology, 38, 273, 10.1159/000088445 · DOI
  2. Althoff, 2012, Genetic and environmental contributions to self-reported thoughts of self-harm and suicide, Am. J. Med. Genet. B Neuropsychiatr. Genet., 159B, 120, 10.1002/ajmg.b.32010 · DOI
  3. Alvarez, 2011, Prevalence and clinical impact of childhood trauma in patients with severe mental disorders, J. Nerv. Ment. Disord., 199, 156, 10.1097/NMD.0b013e31820c751c · DOI · Paper page
  4. Angst, 2005, Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up, Arch. Suicide Res., 9, 279, 10.1080/13811110590929488 · DOI · Paper page
  5. Antypa, 2013, Clinical, psychological and environmental predictors of prospective suicide events in patients with bipolar disorder, J. Psychiatry, 47, 1800
  6. Antypa, 2013, Serotonergic genes and suicide: a systematic review, Eur. Neropsychopharmacol., 23, 1125, 10.1016/j.euroneuro.2013.03.013 · DOI · Paper page
  7. Antypa, 2016, Clinical and genetic factors associated with suicide in mood disorder patients, Eur. Arch. Psychiatry Clin. Neurosci., 266, 181, 10.1007/s00406-015-0658-1 · DOI
  8. Arsenualt-Lapierre, 2004, Psychiatric diagnoses in 3257 suicides: a meta-analysis, BMC Psychiatry, 4, 37, 10.1186/1471-244X-4-37 · DOI · Paper page
  9. Asberg, 1997, Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies, Ann. N. Y. Acad. Sci., 836, 158, 10.1111/j.1749-6632.1997.tb52359.x · DOI · Paper page
  10. Axelsson, 1992, Factors predicting suicide in psychotic patients, Eur. Arch. Psychiatry Clin. Neurosci., 241, 259, 10.1007/BF02195974 · DOI
  11. Azorin, 2009, Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French national cohort, Compr. Psychiatry, 50, 115, 10.1016/j.comppsych.2008.07.004 · DOI
  12. Baillargeon, 2009, Psychiatric disorders and suicide in the nation's largest state prision system, J. Am. Acad. Psychiatry Law, 37, 188
  13. Baldessarini, 2006, Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review, Bipolar Disord., 8, 625, 10.1111/j.1399-5618.2006.00344.x · DOI · Paper page
  14. Baldessarini, 1999, Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders, J. Clin. Psychiatry, 60, 77
  15. Baldessarini, 2003, Lithium treatment and suicide risk in major affective disorders: update and new findings, J. Clin. Psychiatry, 64, 44
  16. Barner – Rasmussen, 1986, Suicide in psychiatric patients in Denmark, 1971 – 1981. II. Hospital utilization and risk groups, Acta Psychiatr. Scand., 73, 449, 10.1111/j.1600-0447.1986.tb02710.x · DOI
  17. Bellivier, 2004, Association between the TPH gene A218C polymorphism and suicidal behaviour: a metanalysis, Am. J. Med. Genet. B Neuropsychiatr. Genet., 124B, 87, 10.1002/ajmg.b.20015 · DOI · Paper page
  18. Ben - Efraim, 2013, Family-based study of HTR2A in suicide attempts: observed gene, gene x environment and parent-of-origin associations, Mol. Psychiatry, 18, 758, 10.1038/mp.2012.86 · DOI
  19. Benazzi, 2004, Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression), Eur. Psychiatry, 19, 85, 10.1016/j.eurpsy.2003.09.008 · DOI
  20. Bloch, 2001, Electroconvulsive therapy in adolescents: similarities to and differences from adults, J. Am. Acad. Child Adolesc. Psychiatry, 40, 1332, 10.1097/00004583-200111000-00014 · doi:10.1097/00004583-200111000-00014
  21. Born, 2005, Newer prophylactic agents for bipolar disorder and their influence on suicidality, Arch. Suicide Res., 9, 301, 10.1080/13811110590929541 · DOI
  22. Bortolato, 2013, The role of the serotonergic system at the interface of aggression and suicide, Neuroscience, 236, 160, 10.1016/j.neuroscience.2013.01.015 · DOI
  23. Bowden, 2004, Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder, JAMA, 291, 939, 10.1001/jama.291.8.939-b · doi:10.1001/jama.291.8.939-b
  24. Brent, 1996, Suicidal behavior runs in families. A controlled family study of adolescents suicide victims, Arch. Gen. Psychiatry, 53, 1145, 10.1001/archpsyc.1996.01830120085015 · DOI · Paper page
  25. Brezo, 2010, Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study, Mol. Psychiatry, 15, 831, 10.1038/mp.2009.19 · DOI · Paper page
  26. Burgess, 2001, Lithium for maintenance treatment of mood disorders, Cochrane Database Syst. Rev., 2
  27. Buttenschon, 2013, An association study of suicide and candidate genes in the serotonergic system, J. Affect. Disord., 148, 291, 10.1016/j.jad.2012.12.011 · DOI
  28. Calati, 2011, Catechol-O-methyltransferase gene modulation on suicidal behavior and personality traits: review,meta-analysis and association study, J. Psychiatry Res., 45, 309, 10.1016/j.jpsychires.2010.07.004 · DOI
  29. Carballo, 2008, Family history of suicidal behaviour and early traumatic experiences: additive effect on suicidality and course of bipolar illness?, J. Affect. Disord., 109, 57, 10.1016/j.jad.2007.12.225 · DOI
  30. Cataldo, 2010, Abnormalities in mitochondrial structure in cells from patients with bipolar disorder, Am. J. Pathol., 177, 575, 10.2353/ajpath.2010.081068 · DOI · Paper page
  31. Clayden, 2012, The association of attempted suicide with genetic variants in the SCL6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analyses, Transl. Psychiatry, 2, 10.1038/tp.2012.96 · DOI
  32. Clements, 2013, Suicide in bipolar disorder in a national English sample, 1996-2009: frequency, trends and characteristics, Psychol. Med., 43, 2593, 10.1017/S0033291713000329 · DOI
  33. Clements, 2013, Suicide in bipolar disorder in a national English sample, 1996-2009: frequency, trends and characteristics, Psychol. Med., 107, 1
  34. Collins, 2008, Divalproex, lithium and suicide among Medicaid patients with bipolar disorder, J. Affect. Disord., 107, 23, 10.1016/j.jad.2007.07.014 · DOI
  35. Courtet, 2004, Implication of genes of the serotonergic system on vulnerability to suicidal behavior, J. Psychiatry Neurosci., 29, 350, 10.1139/jpn.0435 · DOI
  36. Courtet, 2005, Suicidal behaviour: relationship between phenotype and serotoninergic genotype, Am. J. Med. Genet. C Semin. Med. Genet., 133C, 25, 10.1002/ajmg.c.30043 · DOI
  37. Coventry, 2010, Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample, Am. J. Med. Genet. B Neuropsychiatr. Genet., 153B, 757, 10.1002/ajmg.b.31044 · DOI
  38. De Paermentier, 1997, Brain alpha-adrenoreceptors in depressed suicides, Brain Res., 757, 60, 10.1016/S0006-8993(97)00138-8 · DOI
  39. Dennehy, 2011, Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorders (STEP-BD), J. Affect. Disord., 133, 423, 10.1016/j.jad.2011.04.036 · DOI
  40. Dunner, 1976, Heritable factors in the severity of affective illness, Biol. Psychiatry, 11, 31
  41. Dwivedi, 2010, Brain-derived neurotrophic factor and suicide pathogenesis, Ann. Med., 42, 87, 10.3109/07853890903485730 · DOI
  42. Dwivedi, 2003, Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in post-mortem brain of suicide subjects, Arch. Gen. Psychiatry, 60, 273, 10.1001/archpsyc.60.3.273 · DOI · Paper page
  43. Dwivedi, 2009, Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK Kinase 1 (MEK1), Int. J. Neuropsychopharmacol., 12, 1337, 10.1017/S1461145709990575 · DOI · Paper page
  44. Ekinci, 2011, Relationship of trait impulsivity with clinical presentation in euthymic bipolar disorder patients, Psychiatry Res., 190, 259, 10.1016/j.psychres.2011.06.010 · DOI
  45. Escriba, 2004, Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims, Neuropsychopharmacology, 29, 1512, 10.1038/sj.npp.1300459 · DOI
  46. Fiori, 2010, Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide, PLoS One, 5, 10.1371/journal.pone.0015146 · DOI
  47. Fudalej, 2010, Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide, Suicide Life Threat. Behav., 40, 553, 10.1521/suli.2010.40.6.553 · DOI
  48. Fukutake, 2008, Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females, Prog. Neuropsychoparmacol. Biol. Psychiatry, 32, 428, 10.1016/j.pnpbp.2008.02.003 · DOI
  49. Galfalvy, 2009, Increased risk of suicide attempt in mood disorders and TPH1 genotype, J. Affect. Disord., 115, 331, 10.1016/j.jad.2008.09.019 · DOI
  50. Galfalvy, 2006, Clinical predictors of suicidal acts after major depression in bipolar disorder: a prospective study, Bipolar Disord., 8, 586, 10.1111/j.1399-5618.2006.00340.x · DOI
  51. Garno, 2005, Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality, J. Clin. Psychiatry, 66, 339, 10.4088/JCP.v66n0310 · DOI
  52. Gelenberg, 2001, Can lithium help to prevent suicide?, Acta Psychiatr. Scand., 104, 161, 10.1034/j.1600-0447.2001.104003161.x · DOI
  53. Ghaemi, 2004, Antidepressant treatment in bipolar versus unipolar depression, Am. J. Psychiatry, 161, 163, 10.1176/appi.ajp.161.1.163 · DOI · Paper page
  54. Gomez, 2016, Trastornos psiquiátricos en los casos de suicidio consumado en un área hospitalaria entre 2007–2010, Rev. Psiquiatr. Salud Ment., 9, 31, 10.1016/j.rpsm.2014.02.001 · DOI
  55. Gonzalez-Pinto, 2011, Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain, J. Clin. Psychiatry, 72, 671, 10.4088/JCP.09m05483yel · DOI
  56. Gonzalez-Pinto, 2006, Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment, Bipolar Disord., 8, 618, 10.1111/j.1399-5618.2006.00368.x · DOI · Paper page
  57. Goodwin, 2003, Suicide risk in bipolar disorder during treatment with lithium and divalproex, JAMA, 290, 1467, 10.1001/jama.290.11.1467 · DOI · Paper page
  58. Goodwin, 2003, Suicide risk in bipolar disorder during treatment with lithium and divalproex, JAMA, 209, 1467, 10.1001/jama.290.11.1467 · DOI · Paper page
  59. Gould, 1989, Suicide clusters: a critical review, Suicide Life Threat. Behav., 19, 17, 10.1111/j.1943-278X.1989.tb00363.x · DOI · Paper page
  60. Green, 2006, Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK, Br. J. Psychiatry, 188, 21, 10.1192/bjp.bp.105.009969 · DOI
  61. Guthrie, 2001, Randomised controlled trial of brief psychological intervention after deliberate self-poisoning, BMJ, 323, 135, 10.1136/bmj.323.7305.135 · DOI · Paper page
  62. Guze, 1970, Suicide and primary affective disorders, Br. J. Psychiatry, 117, 437, 10.1192/bjp.117.539.437 · DOI · Paper page
  63. Guzzeta, 2007, Lithium treatment reduces suicide risk in recurrent major depressive disorder, J. Clin. Psychiatry, 68, 380, 10.4088/JCP.v68n0304 · DOI · Paper page
  64. Harris, 1998, Excess mortality of mental disorder, Br. J. Psychiatry, 173, 11, 10.1192/bjp.173.1.11 · DOI · Paper page
  65. Hawton, 1998, Deliberate self-harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition, BMJ, 317, 441, 10.1136/bmj.317.7156.441 · DOI · Paper page
  66. Hawton, 2005, Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors, J. Clin. Psychiatry, 66, 693, 10.4088/JCP.v66n0604 · DOI · Paper page
  67. Henry, 2003, Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer, J. Clin. Psychiatry, 64, 331, 10.4088/JCP.v64n0316 · DOI · Paper page
  68. Hepp, 2004, Psychological and psychosocial interventions after attempted suicide: an overview of treatment studies, Crisis, 25, 108, 10.1027/0227-5910.25.3.108 · DOI
  69. Höfer, 2016, The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on attempt and suicide risk in depressed patients with insufficient response to treatment - a European Multicentre Study, Int. Clin. Psychopharmacol., 31, 1, 10.1097/YIC.0000000000000101 · DOI
  70. Hong, 2003, Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior, Neuropsychobiology, 48, 186, 10.1159/000074636 · DOI · Paper page
  71. Hoyer, 2004, Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973–1993, J. Affect. Disord., 78, 209, 10.1016/S0165-0327(02)00311-7 · DOI
  72. Huber, 2014, Altitude is a risk factor for completed suicide in bipolar disorder, Med. Hypotheses, 82, 377, 10.1016/j.mehy.2014.01.006 · DOI
  73. Inskip, 1998, Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia, Br. J. Psychiatry, 172, 35, 10.1192/bjp.172.1.35 · DOI · Paper page
  74. Isometsa, 2014, Suicidal behaviour in mood disorders – who, when, and why?, Can. J. Psychiatry, 59, 120, 10.1177/070674371405900303 · DOI · Paper page
  75. Isometsa, 1995, Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides, J. Affect. Disord., 33, 99, 10.1016/0165-0327(94)00079-O · DOI
  76. Isometsa, 1994, Suicide in bipolar disorder in Finland, Am. J. Psychiatry, 151, 1020, 10.1176/ajp.151.7.1020 · DOI · Paper page
  77. Jacobs, 2003, Practice guideline for the assessment and treatment of patients with suicidal behaviors, Am. J. Psychiatry, 160, 1
  78. Jamison, 2000, Suicide and bipolar disorder, J. Clin. Psychiatry, 61, 47
  79. Jimenez, 2014, Association between GSK3β gene and increased impulsivity in bipolar disorder, Eur. Neuropsychopharmacol., 24, 510, 10.1016/j.euroneuro.2014.01.005 · DOI
  80. Jimenez, 2013, Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients, Eur. Neuropsychopharmacol., 23, 1452, 10.1016/j.euroneuro.2013.01.007 · DOI
  81. Jou, 2009, Mitochondrial dysfunction in psychiatric disease, Chan Gung Med. J., 32, 370
  82. Karch, 2006, Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System, Injury Prev., 12, 22, 10.1136/ip.2006.013557 · DOI
  83. Kato, 2006, The role of mitochondrial dysfunction in bipolar disorder, Drug News Perspect., 19, 597, 10.1358/dnp.2006.19.10.1068006 · DOI
  84. Kato, 2007, Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications, CNS Drugs, 21, 1, 10.2165/00023210-200721010-00001 · DOI
  85. Katz, 1980, Role of serotoninergic mechanisms in animal models of predation, Prog. Neuropsychoparmacol., 4, 219, 10.1016/0364-7722(80)90041-7 · DOI
  86. Ke, 2006, Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide, Brain Res., 1122, 24, 10.1016/j.brainres.2006.09.007 · DOI
  87. Kessing, 2005, Suicide risk in patients treated with lithium, Arch. Gen. Psychiatry, 62, 860, 10.1001/archpsyc.62.8.860 · DOI · Paper page
  88. Khalsa, 2008, Suicidal events and accidents in 216 first – episode bipolar I disorder patients: predictive factors, J. Affect. Disord., 106, 179, 10.1016/j.jad.2007.05.027 · DOI
  89. Kim, 2008, Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the met allele with suicidal behaviour of bipolar patients, Neuropsychobiology, 58, 97, 10.1159/000162356 · DOI
  90. Kohli, 2010, Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients, Arch. Gen. Psychiatry, 67, 348, 10.1001/archgenpsychiatry.2009.201 · DOI
  91. Konradi, 2004, Molecular evidence for mitochondrial dysfunction in bipolar disorder, Arch. Gen. Psychiatry, 61, 300, 10.1001/archpsyc.61.3.300 · DOI · Paper page
  92. Kovacsics, 2009, Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies, Annu. Rev. Pharmacol. Toxciol., 49, 175, 10.1146/annurev.pharmtox.011008.145557 · DOI
  93. Lemonde, 2003, Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide, J. Neurosci., 23, 8788, 10.1523/JNEUROSCI.23-25-08788.2003 · DOI · Paper page
  94. Leverich, 2002, Early physical and sexual abuse associated with an adverse course of bipolar illness, Biol. Psychiatry, 51, 288, 10.1016/S0006-3223(01)01239-2 · DOI · Paper page
  95. Levi, 2003, Trends in mortality from suicide, 1965-99, Acta Psychiatr. Scand., 108, 341, 10.1034/j.1600-0447.2003.00147.x · DOI · Paper page
  96. Li, 2006, Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotyping meta-analyses, Hum. Genet., 119, 233, 10.1007/s00439-005-0113-x · DOI
  97. Li, 2007, Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behaviour, Mol. Psychiatry, 12, 47, 10.1038/sj.mp.4001890 · DOI · Paper page
  98. Liberati, 2009, The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med., 6, 10.1371/journal.pmed.1000100 · DOI · Paper page
  99. Licht, 2008, Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up, Bipolar Disord., 10, 79, 10.1111/j.1399-5618.2008.00499.x · DOI
  100. Lin, 1998, Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital, Gen. Hosp. Psychiatry, 20, 98, 10.1016/S0163-8343(98)00003-6 · DOI
  101. Lin, 2004, Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis, Biol. Psychiatry, 55, 1023, 10.1016/j.biopsych.2004.02.006 · DOI · Paper page
  102. Liu, 2008, Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder, Psychiatr. Genet., 18, 267, 10.1097/YPG.0b013e3283060f59 · DOI
  103. Lohoff, 2005, Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder, Am. J. Med. Genet. B Neuropsychiatr. Genet., 139B, 51, 10.1002/ajmg.b.30215 · DOI
  104. Lopez, 2001, Suicide attempts in bipolar patients, J. Clin. Psychiatry, 62, 963, 10.4088/JCP.v62n1208 · DOI
  105. Lopez, 2007, National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium. Nested association between genetic variation in tryptophan hydroxylase II, Bipolar affective disorder, and suicide attempts, Biol. Psychiatry, 61, 181, 10.1016/j.biopsych.2006.03.028 · DOI
  106. Mackinnon, 2005, Rapid mood switching and suicidality in familial bipolar disorder, Bipolar Disord., 7, 441, 10.1111/j.1399-5618.2005.00236.x · DOI
  107. MacQueen, 2001, Bipolar II disorder: symptoms, course, and response to treatment, Psychiatr. Serv., 52, 358, 10.1176/appi.ps.52.3.358 · DOI
  108. Magno, 2010, No Association between AKT1 but not AKT1P genetic variants and increased risk for suicidal behavior in bipolar patients, Genes Brain Behav., 9, 411, 10.1111/j.1601-183X.2010.00571.x · DOI
  109. Mann, 2002, A current perspective of suicide and attempted suicide, Ann. Internal Med., 136, 302, 10.7326/0003-4819-136-4-200202190-00010 · DOI · Paper page
  110. Mann, 2001, The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system, Neuropsychopharmacology, 24, 467, 10.1016/S0893-133X(00)00228-1 · DOI · Paper page
  111. Marangell, 2008, Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD, J. Clin. Psychiatry, 69, 916, 10.4088/JCP.v69n0605 · DOI
  112. Martin-Guerrero, 2006, The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers, Psychopharmacology (Berl.), 184, 82, 10.1007/s00213-005-0266-2 · DOI
  113. Maser, 2002, Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behaviour? A 14-year prospective study, Suicide Life – Threat Behav, 32, 10, 10.1521/suli.32.1.10.22183 · DOI · Paper page
  114. McGuffin, 2001, What can psychiatric genetics offer suicidology, Crisis, 22, 61, 10.1027//0227-5910.22.2.61 · DOI
  115. McGuffin, 2010, The genetics of affective disorder and suicide, Eur. Psychiatry, 25, 275, 10.1016/j.eurpsy.2009.12.012 · DOI
  116. McIntyre, 2008, Bipolar disorder and suicide: research synthesis and clinical translation, Curr. Psychiatry, 10, 66, 10.1007/s11920-008-0012-7 · DOI
  117. McIntyre, 2008, Bipolar disorder and suicide: research synthesis and clinical translation, Curr. Psychiatry Rep., 10, 66, 10.1007/s11920-008-0012-7 · DOI
  118. Meltzer, 2003, Reducing the risk for suicide in schizophrenia and affective disorders, J. Clin. Psychiatry, 64, 1122, 10.4088/JCP.v64n0920 · DOI
  119. Mirkovic, 2016, A review of the past 10 years, progress, limitations, and future directions, Front Psychiatry, 158
  120. Moller, 2006, Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review, Eur. Arch. Psychiatry Clin. Neurosci., 256, 329, 10.1007/s00406-006-0650-x · DOI
  121. Muller, 2006, Brain-derived neurotrophic factor (BDNF) gene and rapid-cylcing bipolar disorder: family-based association study, Br. J. Psychiatry, 189, 317, 10.1192/bjp.bp.105.010587 · DOI
  122. Murphy, 2011, Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B & NTRK2 polymorphisms, Behav. Brain Funct., 7, 22, 10.1186/1744-9081-7-22 · DOI
  123. Musil, 2013, Genetics of emergent suicidality during antidepressive treatment – data from a naturalistic study on a large sample of inpatients with a major depressive episode, Eur. Neuropsychopharmacol., 23, 663, 10.1016/j.euroneuro.2012.08.009 · DOI
  124. Neves, 2010, Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients?, J. Affect. Disord., 125, 98, 10.1016/j.jad.2009.12.026 · DOI
  125. Ono, 2004, Association between cathecol-O-methyltransferase functional polymorphism and male suicide completers, Neuropsychopharmacology, 75, 807
  126. Oquendo, 2010, Increased risk for suicidal behaviour in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), J. Clin. Psychiatry, 71, 902, 10.4088/JCP.09m05198gry · DOI · Paper page
  127. Oquendo, 2004, Rates of lifetime suicide attempt and rates of lifetime major depression in different ethnic groups in the United States, Acta Psychiatr. Scand., 110, 446, 10.1111/j.1600-0447.2004.00404.x · DOI
  128. Osborn, 2008, Suicide and severe mental illnesses. Cohort study within the UK general practice research database, Schizophr. Res., 99, 134, 10.1016/j.schres.2007.11.025 · DOI
  129. Owen, 2015, A qualitative investigation into the relationship between social factors and suicidal thoughts and acts experienced by people with a bipolar disorder diagnosis, J. Affect. Disord., 176, 133, 10.1016/j.jad.2015.02.002 · DOI
  130. Pandey, 2007, Cyclic amp response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus, Int. J. Neuropsychopharmacol., 10, 621, 10.1017/S1461145706007231 · DOI
  131. Patorno, 2010, Anticonvulsant medications and the risk of suicide, attempted suicide, or violent deaths, JAMA, 303, 1401, 10.1001/jama.2010.410 · DOI · Paper page
  132. Pawlak, 2013, Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders, Gen. Hosp. Psychiatry, 35, 427, 10.1016/j.genhosppsych.2013.03.014 · DOI
  133. Perroud, 2012, Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project, Pharmacogenomics J., 12, 68, 10.1038/tpj.2010.70 · DOI
  134. Pivac, 2011, The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide, Genes Brain Behav., 10, 565, 10.1111/j.1601-183X.2011.00695.x · DOI
  135. Pompili, 2013, Epidemiology of suicide in bipolar disorders: a systematic review of the literature, Bipolar Disord., 5, 457, 10.1111/bdi.12087 · DOI · Paper page
  136. Pompili, 2013, Epidemiology of suicide in bipolar disorders: a systematic review of literature, Bipolar Disord., 15, 457, 10.1111/bdi.12087 · DOI · Paper page
  137. Pompili, 2009, Assessment and treatment of suicide risk in bipolar disorders, Exp. Rev. Neurother., 9, 109, 10.1586/14737175.9.1.109 · DOI
  138. Pregelj, 2011, The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide, J. Affect. Disord., 128, 287, 10.1016/j.jad.2010.07.001 · DOI · Paper page
  139. Quiroz, 2008, Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder, Neuropsychopharmacology, 33, 2551, 10.1038/sj.npp.1301671 · DOI · Paper page
  140. Ratta-Apha, 2013, Association study of BDNF with completed suicide in the Japanese population, Psychiatry Res., 209, 734, 10.1016/j.psychres.2013.05.030 · DOI
  141. Ray, 2011, Hypobaric hypoxia modulates brain biogenic amines and disturbs sleep architecture, Neurochem. Int., 58, 112, 10.1016/j.neuint.2010.11.003 · DOI
  142. Reutfors, 2009, Seasonality of suicide in Sweden: relationship with psychiatric disorder, J. Affect. Disord., 119, 59, 10.1016/j.jad.2009.02.020 · DOI
  143. Rezin, 2009, Mitochondrial dysfunction and psychiatric disorders, Neurochem. Res., 34, 1021, 10.1007/s11064-008-9865-8 · DOI · Paper page
  144. Rihmer, 2006, Do antidepressant t(h)reat(en) depressives? Towards clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries, J. Affect. Disord., 94, 3, 10.1016/j.jad.2006.04.003 · DOI
  145. Rihmer, 1990, Suicide in subtypes of primary major depression, J. Affect. Disord., 18, 221, 10.1016/0165-0327(90)90039-B · DOI
  146. Rihmer, 1990, Suicide in subtypes of primary major depression, J. Affect. Disord., 18, 221, 10.1016/0165-0327(90)90039-B · DOI
  147. Rihmer, 2001, Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary, J. Affect. Disord., 67, 175, 10.1016/S0165-0327(01)00309-3 · DOI
  148. Roy, 1982, Risk factors for suicide in psychiatric patients, Arch. Gen. Psychiatry, 39, 1089, 10.1001/archpsyc.1982.04290090071014 · DOI · Paper page
  149. Roy, 2001, Suicidal behaviour in twins: a replication, J. Affect. Disord., 66, 71, 10.1016/S0165-0327(00)00275-5 · DOI
  150. Roy, 1991, Suicide in twins, Arch. Gen. Psychiatry, 48, 29, 10.1001/archpsyc.1991.01810250031003 · DOI · Paper page
  151. Saiz, 2011, Role of serotonergic-related systems in suicidal behavior: data from a case-control association study, Prog. Neuropsychoparmacol. Biol. Psychiatry, 35, 1518, 10.1016/j.pnpbp.2011.04.011 · DOI
  152. Samadi Rad, 2012, Serotonin 1A receptor genetic variations, suicide, and life events in the Iranian population, Psychiatry Clin. Neurosci., 66, 337, 10.1111/j.1440-1819.2012.02333.x · DOI
  153. Scaglia, 2010, The role of mitochondrial dysfunction in psychiatric disease, Dev. Disabil.Res. Rev., 16, 136, 10.1002/ddrr.115 · DOI
  154. Schou, 2000, Suicidal behaviour and prophylactic lithium treatment of major mood disorders: a review of reviews, Suicide Life Threat. Behav., 30, 289, 10.1111/j.1943-278X.2000.tb00993.x · DOI
  155. Sears, 2013, Investigating the role of BDNF and CCK system genes in suicidality in a familial bipolar cohort, J. Affect. Disord., 151, 611, 10.1016/j.jad.2013.07.006 · DOI
  156. Segal, 2006, Association between suicide attempts in south Brazilian depressed patients with the serotonin transporter polymorphism, Psychiatry Res., 143, 289, 10.1016/j.psychres.2005.03.008 · DOI
  157. Sequeira, 2004, Alpha 2A adrenergic receptor gene and suicide, Psychiatry Res., 125, 87, 10.1016/j.psychres.2003.12.002 · DOI
  158. Simon, 2007, Risk of suicide attempt and suicide death in patients treated for bipolar disorder, Bipolar Disord., 9, 526, 10.1111/j.1399-5618.2007.00408.x · DOI · Paper page
  159. Simon, 2007, Risk of suicide attempt and suicide death in patients treated for bipolar disorder, Bipolar Disord., 526, 10.1111/j.1399-5618.2007.00408.x · DOI · Paper page
  160. Sondergard, 2008, Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide, Bipolar Disord., 10, 87, 10.1111/j.1399-5618.2008.00464.x · DOI
  161. Stefulj, 2006, TPH gene polymorphism and aging: indication of combined effect on the predisposition to violent suicide, Am. J. Med. Genet. B Neuropsychiatr. Genet., 141B, 139, 10.1002/ajmg.b.30271 · DOI
  162. Stein, 2017, Genomewide association studies of suicide attempts in US soldiers, Am. J. Med. Genet. B Neuropsychiatr. Genet., 786, 10.1002/ajmg.b.32594 · DOI
  163. Stork, 2005, Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research, Mol. Psychiatry, 10, 900, 10.1038/sj.mp.4001711 · DOI · Paper page
  164. Swann, 2009, Increased trait-like impulsivity and course of illness in bipolar disorder, Bipolar Disord., 11, 280, 10.1111/j.1399-5618.2009.00678.x · DOI · Paper page
  165. Takizawa, 2012, Suicide due to mental diseases based on the Vital Statistics Survey Death Form, Nihon Koshu Eisei Zasshi, 59, 399
  166. Tidelman, 2008, Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long – term follow-up, BMJ, 337, a2205, 10.1136/bmj.a2205 · DOI · Paper page
  167. Tondo, 1999, Suicide attempts in major affective disorder patients with comorbid substance use disorders, J. Clin. Psychiatry, 60, 63
  168. Tondo, 2003, Suicidal behaviour in bipolar disorder: risk and prevention, CNS Drugs, 17, 491, 10.2165/00023210-200317070-00003 · DOI · Paper page
  169. Tovilla-Zarate, 2011, No association between COMT val158met polymorphism and suicidal behavior; meta-analysis and new data, BMC Psychiatry, 11, 151, 10.1186/1471-244X-11-151 · DOI
  170. Trouvin, 1986, Rat brain monoamine metabolism and hypobaric hypoxia: a new approach, Gen. Pharmacol., 17, 69, 10.1016/0306-3623(86)90013-3 · DOI
  171. Tsai, 1996, Comorbidity of substance abuse in patients with bipolar disorder: a 15-year follow-up study, Taiwan J. Psychiatry, 10, 357
  172. Tsai, 1997, Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder, J. Affect. Disord., 46, 143, 10.1016/S0165-0327(97)00099-2 · DOI
  173. Tsai, 1999, Characteristics and psychosocial problems of patients with bipolar disorder at high risk for suicide attempts, J. Affect. Disord., 52, 145, 10.1016/S0165-0327(98)00066-4 · DOI
  174. Tsai, 2002, Risk factors for completed suicide in bipolar disorder, J. Clin. Psychiatry, 63, 69, 10.4088/JCP.v63n0602 · DOI
  175. Videtic, 2009, Suicide, stress and serotonin receptor 1A promoter polymorphism -1019C>G in Slovenian suicide victims, Eur. Arch. Psychiatry Clin. Neurosci., 259, 234, 10.1007/s00406-008-0861-4 · DOI
  176. Vieta, 1997, Suicidal behavior in bipolar I and bipolar II disorder, J. Nerv. Ment. Disord., 185, 407, 10.1097/00005053-199706000-00008 · DOI
  177. Vieta, 1999, Personality disorders in bipolar II patients, J. Nerv. Ment. Dis., 187, 245, 10.1097/00005053-199904000-00009 · DOI
  178. Vieta, 2018, Early intervention in bipolar disorder, Am. J. Psychiatry, 1, 411, 10.1176/appi.ajp.2017.17090972 · DOI · Paper page
  179. Vincze, 2008, Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene, Bipolar Disord., 10, 580, 10.1111/j.1399-5618.2008.00603.x · DOI
  180. Walther, 2003, Synthesis of serotonin by a second tryptophan hydroxylase isoform, Science, 299, 76, 10.1126/science.1078197 · DOI · Paper page
  181. Wasserman, 2007, Association of the serotonin transporter promotor polymorphism with suicide attempters wiath a high medical damage, Eur. Neuropsychopharmacol., 17, 230, 10.1016/j.euroneuro.2006.08.006 · DOI
  182. Wasserman, 2012, The European Psychiatric Association (EPA) guidance on suicide treatment and prevention, Eur. Psychiatry, 27, 129, 10.1016/j.eurpsy.2011.06.003 · DOI · Paper page
  183. Yatham, 2009, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009, Bipolar Disord., 11, 225, 10.1111/j.1399-5618.2009.00672.x · DOI · Paper page
  184. Yerevanian, 2007, Bipolar pharmacotherapy and suicidal behaviour. Part I. Lithium, divalproex and carbamazepine, J. Affect. Disord., 103, 5, 10.1016/j.jad.2007.05.019 · DOI
  185. Yerevanian, 2007, Bipolar pharmacotherapy and suicidal behaviour. Part 2. The impact of antidepressants, J. Affect. Disord., 103, 13, 10.1016/j.jad.2007.05.017 · DOI
  186. Zai, 2012, The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis, Int. J. Neuropsychopharmacol., 15, 1037, 10.1017/S1461145711001313 · DOI
  187. Zarrilli, 2009, Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases, Am. J. Med. Genet. B Neuropsychiatr. Genet., 150B, 599, 10.1002/ajmg.b.30849 · DOI
  188. Zill, 2004, Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims, Biol. Psychiatry, 56, 581, 10.1016/j.biopsych.2004.07.015 · DOI · Paper page
  189. Zouk, 2007, The effect of genetic variation of the serotonin 1B receptor gene on impulssive agressive behavior and suicide, Am. J. Med. Genet. B Neuropsychiatr. Genet., 144B, 996, 10.1002/ajmg.b.30521 · DOI

Cited by

See all 269

Metadata

Authors
Plans, L., Barrot, C., Nieto, E., Rios, J., Schulze, T. G., Papiol, S., Mitjans, M., Vieta, E., & Benabarre, A.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2019-01
Volume
242
Pages
111-122
ISSN
0165-0327 (ISSN-L)
DOI
10.1016/j.jad.2018.08.054
OpenAlex
W2888193947
Cited by
269
References
34
FWCI
3.77
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Spanish Ministry of Economy (PI15/00283)
  • FEDER
  • CIBERSAM (2017 SGR 1365, SLT006/17/00357)
  • CERCA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between completed suicide and bipolar disorder: A systematic review of the literature. https://app.cochat.ai/papers/10.1016/j.jad.2018.08.054
The paper
Plans, L., Barrot, C., Nieto, E., Rios, J., Schulze, T. G., Papiol, S., Mitjans, M., Vieta, E., & Benabarre, A. (2019). Association between completed suicide and bipolar disorder: A systematic review of the literature. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.08.054

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.